Radiomics: a potential biomarker for N2 malignancy in clinical stage I lung adenocarcinoma
Transl Lung Cancer Res
.
2020 Aug;9(4):1623-1624.
doi: 10.21037/tlcr-20-683.
Authors
Jiajun Deng
1
,
Yunlang She
1
,
Minglei Yang
1
2
,
Lei Zhang
1
,
Dong Xie
1
,
Chang Chen
1
Affiliations
1
Department of Thoracic Surgery, Tongji University Affiliated Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.
2
Department of Thoracic Surgery, Ningbo No. 2 Hospital, Chinese Academy of Sciences, Ningbo, China.
PMID:
32955508
PMCID:
PMC7481646
DOI:
10.21037/tlcr-20-683
No abstract available